Ravi S. Chari, SVP-Clinical Excellence at HCA Holdings, Inc. (HCA), sold 31,956 shares at $90.00 ($2.9M) on 2017-03-27, disclosed to the SEC on 2017-03-29.
Scheduled sale ($2.9M) by SVP-Clinical Excellence under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| HCA | SELL | 2015-08-07 | $1.0M | — | Filing → |